960 x 350_30

Assay development for large-scale clinical studies

Supporting data from high-volume, regulated clinical studies

Taking a candidate drug to market – and to the patients who will benefit from it – requires supporting data from high-volume, regulated clinical studies. From sample receipt to final reporting, Q2 Solutions understands the importance of delivering qualified clinical sample data throughout all stages of the drug development cycle.

Q2 Solutions’ bioanalytical experts can partner with you to develop biomarker assays and cell-based bioanalytical assays that incorporate state-of-the-art instrumentation, rigorous quality control, and a logistics infrastructure to support large-scale, international studies.

Q2 Solutions can support your large-scale clinical projects by leveraging:

  • Expertise in developing assays for human samples
    Q2 Solutions has earned a reputation for excellence in method development through our experience with assaying human samples. Transitioning from animal studies to human subjects requires assays that can measure novel metabolites and accommodate low-level dosing studies. Q2 Solutions will work with you to develop automated small molecule LC/MS assays, large molecule ligand binding assays, and large-molecule hybrid-LC/MS assays including high resolution mass spectrometry, to support all phases of the clinical trial process.
  • An end-to-end assay development process
    Recognizing that a clinical assay must be reliable over a period of years, Q2 Solutions has implemented a rigorous procedure to ensure quality and reduce risk. Prior to validation, each assay undergoes a formal pre-qualification process in which Q2 Solutions scientists review preliminary data and assess modifications necessary to support validation.
  • Project managers with scientific expertise
    All Q2 Solutions Project Managers are scientists with hands-on experience in analytical methodologies. Our Managers understand the science behind the assays, verifying data quality and assuring that assays run smoothly for the duration of the project. Through weekly or bi-weekly updates, our Project Managers will address concerns or questions as they arise and serve as active collaborators in decision-making.
  • A Global Presence to Support International Studies. Q2 Solutions combines local expertise with a global logistics network to support sample processing for international clinical studies. With facilities in the United States and China, Q2 Solutions complies with global bioanalytical regulatory guidance. Q2 Solutions is certified by ANVISA, the Brazilian health regulatory agency.
  • Flexibility with Transparency. All assays carried out at Q2 Solutions facilities adhere to a common set of SOPs, thereby assuring consistent data quality. Bioanalytical and clinical Project Managers from different internal teams communicate regularly to resolve sample processing issues in a timely and transparent manner. Q2 Solutions bioanalytical laboratories integrate with central facilities, offering a flexibility to adapt to shifting analytical demands and customer timelines.
 
Q² Solutions provided bioanalytical support for two randomized, double-blind, Phase III studies to assess the long-term safety and efficacy of various dosing regimens of a novel new drug and a comparator drug in targeted patient population groups. Over a four-year period, Q² Solutions assayed the pharmacokinetic profile of the compound and its major metabolite in plasma. Collectively, these studies required the analysis of over 50,300 samples (including placebos) from more than 29,000 subjects. For the larger study, samples were provided by nearly 1,400 centers located in 46 countries. A final bioanalytical report of over 8,000 pages was written in five weeks to meet an aggressive regulatory submission date. Results from these multi-institutional studies ultimately supported the U.S. Food and Drug Administration’s approval of the drug.

— Q² Solutions

Translating a large-scale, long-term study into a successful outcome requires reliable, qualified measurements at a clinical scale. Q2 Solutions’ bioanalytical experts can help you design and carry out validated assays that will support all stages of your clinical study.

> 1 million bioanalytical and ADME tests performed yearly

Related Thought Leaders Insights


Hybrid Assays for Protein Bioanalysis

Authors: Steve Lowes, Ph.D., Senior Director, Bioanalytical Services Barry Jones, Ph.D., Director, LC-MS Biologics and Biomarkers Hybrid assays are powerful tools for protein bioanalysis of both...

Quantitative Assays for Peptides using LC-MS

We are one of the few bioanalytical laboratories successfully employing immunoprecipitation techniques, HRMS, and multi-dimensional liquid chromatography for the quantitation of peptide and protein...

Developing Assays for Novel Drugs

Novel drugs with complex design are becoming more common to treat difficult diseases. This insight brief, authored by Michael Brown, Ph.D., Senior Director, Immunoanalytical Services and Barry Jones,...